OR Oncology Reports 1021-335X 1791-2431 D.A. Spandidos 10.3892/or.2022.8385 OR-48-04-08385 Retraction MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways ZhangMin LiQiongxia PanYingzhe WangHui LiuGang YinHui 10 2022 08 08 2022 48 4 170 Copyright: © Zhang et al. 2022 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Oncol Rep 39: 2040–2050, 2018; DOI: 10.3892/or.2018.6264

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that data shown in various of the panels portraying the results from flow cytometric experiments in Fig. 2D, 5D and 6D were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.